Aslihan Ayse Buber

1PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Oct 31, 2022
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.

Ahmet Omma, Ayse Batirel, Mehtap Aydin

Pageof 1

Frequent Collaborators

1 joint publications

Ahmet Omma

1 joint publications

Ayse Batirel

1 joint publications

Mehtap Aydin

1 joint publications

Fatma Yilmaz Karadag

1 joint publications

Abdulsamet Erden

1 joint publications

Orhan Kucuksahin

1 joint publications

Berkan Armagan

1 joint publications

Serdar Can Güven

1 joint publications

Ozlem Karakas

1 joint publications

Selim Gokdemir

Frequent Collaborators

1 joint publications

Ahmet Omma

1 joint publications

Ayse Batirel

1 joint publications

Mehtap Aydin

1 joint publications

Fatma Yilmaz Karadag

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.7K
See more related videos

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

8.7K
See more related videos